Stockholders' Deficit (Detail) - USD ($) $ in Thousands		3 Months Ended
		Mar. 22, 2020	Mar. 24, 2019
Stockholders' Deficit [Line Items]
Balance	[1]	$ (3,415,759)
Net income		121,602	$ 92,650
Balance		$ (3,392,190)
Common Stock [Member]
Stockholders' Deficit [Line Items]
Balance (in shares)		38,934,009	40,977,561
Balance		$ 389	$ 410
Issuance and cancellation of stock awards, net, (in shares)		1,645	8,240
Tax payments for restricted stock upon vesting, (in shares)		(5,929)	(9,064)
Purchases of common stock, (in shares)		(271,064)	(33,549)
Purchases of common stock		$ (3)
Exercises of stock options, (in shares)		380,938	140,702
Exercises of stock options		$ 4	$ 1
Balance (in shares)		39,039,599	41,083,890
Balance		$ 390	$ 411
Additional Paid-in Capital [Member]
Stockholders' Deficit [Line Items]
Balance		243	569
Tax payments for restricted stock upon vesting		(1,796)	(2,467)
Purchases of common stock		(988)	(1,782)
Exercises of stock options		10,101	4,536
Non-cash compensation expense		4,914	4,608
Balance		12,474	5,464
Retained Deficit [Member]
Stockholders' Deficit [Line Items]
Balance		(3,412,649)	(3,036,471)
Net income		121,602	92,650
Dividends declared on common stock and equivalents		(30,442)	(26,665)
Purchases of common stock		(78,599)	(6,362)
Adoption of ASC 326 (Note 9)		1,102
Balance		(3,398,986)	(2,976,848)
Accumulated Other Comprehensive Income (Loss) [Member]
Stockholders' Deficit [Line Items]
Balance		(3,742)	(4,429)
Currency translation adjustment		(2,326)	237
Balance		$ (6,068)	$ (4,192)

[1] The balance sheet at December 29, 2019 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.